Article AbstractBecause this piece does nothave an abstract, we have provided for your benefit the first 3 sentencesof the full text.Sir: The article by Zajecka et al.1on the efficacy and safetyof divalproex sodium versus olanzapine in the treatment ofbipolar disorder is interesting, but unfortunately it does notseem to truly support the authors†conclusions.The first problem is sample size. According to previous experience with divalproex2and olanzapine,3this study was notclearly powered to show superiority of either drug over theother and it is unclear whether this trial was designed to proveeither superiority or noninferiority.†‹†‹
Mauricio Tohen, Eduard Vieta, Guy M. Goodwin, Bin Sun, Jay D. Amsterdam, Michael Banov, Anantha Shekhar, Scott T. Aaronson, L. M. Bardenstein, I Grecu-Gaboş, В А Точилов, Dan Prelipceanu, Heather S. Oliff, Ludmila Kryzhanovskaya, Charles L. Bowden
Ross J. Baldessarini, John Hennen, Michael G. Wilson, Joseph R. Calabrese, Roy Chengappa, Paul E. Keck, Susan L. McElroy, Gary Sachs, Eduard Vieta, Jeffrey A. Welge, Lakshmi N. Yatham, Carlos A. Zarate, Robert W. Baker, Mauricio Tohen
Mauricio Tohen, Eduard Vieta, Julia Amsterdam, Scott T. Aaronson, Bin Sun, Charles L. Bowden, Michael Banov, Anantha Shekhar, Heather S. Oliff, L. Kryzhanovskaya
Jorge M. Tamayo, Guido Mazzotti, Mauricio Tohen, Wagner F. Gattaz, Ricardo Zapata, José J. Cuenca Castillo, Rodolfo D. Fahrer, Ana González‐Pinto, Eduard Vieta, J.-M. Azorin, Eileen Brown, Eric J. Brunner, Jorge Rovner, Elena Bonett-Perrin, Robert W. Baker
Discussion(0)
No comments yet. Be the first to comment.